NASDAQ:DRAD Digirad (DRAD) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free DRAD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.87▼$0.9250-Day Range$2.79▼$4.6552-Week Range$1.99▼$8.84Volume8,235 shsAverage Volume485,592 shsMarket Capitalization$4.18 millionP/E RatioN/ADividend Yield250.54%Price TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Digirad alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Digirad Stock (NASDAQ:DRAD)Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. DRAD Stock News HeadlinesJanuary 7, 2024 | nasdaq.comApril 19th Options Now Available For Karuna Therapeutics (KRTX)May 20, 2023 | cbsnews.com2 girls dead, 1 hospitalized after possible overdoses at high schoolApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. April 23, 2023 | usatoday.comConnecticut teachers thought 5-year-old boy was just 'playing dead' before he died, lawsuit claimsJanuary 16, 2023 | nypost.comLisa Marie Presley dead at 54 after cardiac arrest: ‘My beautiful daughter’January 14, 2023 | foxnews.comRock icon Jeff Beck dead at 78October 12, 2022 | businesswire.comGlobal Nuclear Medicine Equipment Market Report to 2030 - Featuring Siemens Healthineers, Fujifilm Holdings, Canon and Digirad Among Others - ResearchAndMarkets.com - Business WireOctober 11, 2022 | finance.yahoo.comGlobal Single Photon Emission Computed Tomography (SPECT) Market to Reach $2.7 Billion by 2027 - Yahoo FinanceApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. October 10, 2022 | prnewswire.com3D Vascular Ultrasound Imaging Market to record USD 344.17 Mn incremental growth; North America to have a significant share -- Technavio - PR NewswireOctober 7, 2022 | finance.yahoo.comOutlook on the Nuclear Medicine Equipment Global Market to 2030 - Rising Adoption of Nuclear Medicine Equipment and Emergence of Innovative & Advanced Equipment is Driving Growth - Yahoo FinanceAugust 26, 2022 | benzinga.comGlobal Single Photon Emission Computed Tomography (SPECT) Market Report 2022-2026: Hybrid SPECT Systems W - BenzingaAugust 25, 2022 | finance.yahoo.comGlobal Single Photon Emission Computed Tomography (SPECT) Market Report 2022: Market to Reach $2.5 Billion by 2026 - SPECT Dominates the Nuclear Medicine Market - Yahoo FinanceAugust 17, 2022 | streetinsider.comMD Office Solutions, LLC, acquires Antigua Medical Services, LLC; a Cardiac Mobile Imaging Company in Arizona - StreetInsider.comAugust 12, 2022 | seekingalpha.comStar Equity Holdings, Inc. (STRR) CEO Rick Coleman on Q2 2022 Results - Earnings Call Transcript - Seeking AlphaJuly 19, 2022 | businesswire.comGlobal Mobile Medical Imaging Services Market Report (2022 to 2027) - Transition of Diagnostic Image Processing Techniques from 2D to 3D Presents Opportunities - ResearchAndMarkets.com - Business WireJuly 16, 2022 | streetinsider.comForm 10-K SOLITRON DEVICES INC For: Feb 28 - StreetInsider.comJune 9, 2022 | benzinga.comGlobal Mobile Imaging Services Market Report 2022-2026: Rise of Home Healthcare - The Cornerstone for the - BenzingaJune 9, 2022 | globenewswire.comNuclear Medicine Equipment Market is projected to record a CAGR of 4.1%, during 2022 - 2032 : Future Market Insights, Inc. - GlobeNewswireApril 29, 2022 | streetinsider.comForm 10-K/A CNS Pharmaceuticals, For: Dec 31 - StreetInsider.comApril 22, 2022 | streetinsider.comForm 8-K STAR EQUITY HOLDINGS, For: Apr 19 - StreetInsider.comApril 8, 2022 | financialpost.comNuclear Imaging Equipment Market worth $3.4 billion by 2025- Exclusive Report by MarketsandMarkets™ - Financial PostMarch 22, 2022 | seekingalpha.comStar Equity Holdings, Inc. (STRR) Management on Q4 2021 Results - Earnings Call Transcript - Seeking AlphaMarch 9, 2022 | prnewswire.com3D Medical Imaging Services Market to Reach $377.06 Bn, Globally, by 2030 at 6.6% CAGR: Allied Market Research - PR NewswireFebruary 21, 2022 | msn.comWho's Hiring In The Cumming Area? See New Local Jobs - Reverb MSN MusicJanuary 18, 2022 | businesswire.comFoldax Appoints Scott Huennekens to Board of Directors - Business WireJanuary 13, 2022 | gurufocus.comStar Equity Holdings, Inc. Iss - GuruFocus.comSee More Headlines Receive DRAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/18/2020Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:DRAD CUSIPN/A CIK707388 Webwww.digirad.com Phone858-726-1600FaxN/AEmployees618Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,630,000.00 Net Margins-5.32% Pretax MarginN/A Return on Equity-3.75% Return on Assets-0.85% Debt Debt-to-Equity Ratio0.88 Current Ratio1.27 Quick Ratio0.91 Sales & Book Value Annual Sales$114.18 million Price / Sales0.04 Cash Flow$1.27 per share Price / Cash Flow0.69 Book Value$10.30 per share Price / Book0.09Miscellaneous Outstanding Shares4,760,000Free FloatN/AMarket Cap$4.18 million OptionableNot Optionable Beta0.18 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Matthew Gabel Molchan (Age 53)Pres, CEO & Director Comp: $705.96kMr. David James Noble (Age 50)CFO & COO Comp: $495.77kMr. Martin B. Shirley (Age 58)Pres of Digirad Imaging Solutions Comp: $427.94kMs. Hannah BibleVP of Legal & Fin.Mr. Bob HalbertSr. Director of Human ResourceKey CompetitorsHelius Medical TechnologiesNASDAQ:HSDTENDRA Life SciencesNASDAQ:NDRANuwellisNASDAQ:NUWETivic Health SystemsNASDAQ:TIVCBioSig TechnologiesNASDAQ:BSGMView All Competitors DRAD Stock Analysis - Frequently Asked Questions How were Digirad's earnings last quarter? Digirad Co. (NASDAQ:DRAD) released its quarterly earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by $0.34. The medical equipment provider had revenue of $30.35 million for the quarter. Digirad had a negative net margin of 5.32% and a negative trailing twelve-month return on equity of 3.75%. Is Digirad a good dividend stock? Digirad (NASDAQ:DRAD) pays an annual dividend of $2.20 per share and currently has a dividend yield of 83.65%. DRAD has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for DRAD. When did Digirad's stock split? Shares of Digirad reverse split on Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What is Matt Molchan's approval rating as Digirad's CEO? 26 employees have rated Digirad Chief Executive Officer Matt Molchan on Glassdoor.com. Matt Molchan has an approval rating of 70% among the company's employees. 57.0% of employees surveyed would recommend working at Digirad to a friend. What other stocks do shareholders of Digirad own? Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Gilead Sciences (GILD), AT&T (T), Exelixis (EXEL), Enphase Energy (ENPH), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), AcelRx Pharmaceuticals (ACRX), Amyris (AMRS), General Electric (GE) and Genocea Biosciences (GNCA). This page (NASDAQ:DRAD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
